Details of the Drug

General Information of Drug (ID: DM3WZXO)

Drug Name

CK0801

Indication

Disease Entry	ICD 11	Status	REF
Hematologic disease	3C0Z	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03773393) A Clinical Trial of CK0801 (a New Drug) in Patients With Bone Marrow Failure Syndrome (BMF). U.S. National Institutes of Health.